NCT Number: NCT00259103
Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labor
The purpose of this study is to assess the safety and efficacy of rhRlx for cervical ripening, when compared to a placebo.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–40 year
Sex eligibility
Female
Study type
Interventional
Phase
Phase 2
Primary location
Novosibirsk State Medical Academy, Novosibirsk, Russia
About this study
A multicenter, randomized, double-blind, placebo-controlled, dose escalation study of healthy female subjects at ≥ 40 weeks gestation and who are scheduled for induction. A dose-escalation portion of the study is followed by a randomized, double-blind, placebo-controlled portion of the study. The endpoints include cervical ripening, as well as progression to labor and delivery.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Age between 18 and 40 years
- Normal pregnancy
- At least 40 weeks of gestation
- Otherwise healthy
Exclusion criteria
- Anemia or hypertension
- Presence of chronic disease
- Endometriosis
- Known fetal anomaly
- Substance abuse
- History of cancer
Treatment and study plan
Placebo
DrugPrimary outcomes
-
Cervical ripening
Time frame: Through 24 hours
Secondary outcomes
-
Progression to active labor and delivery
Time frame: Within 7 Days of Drug Infusion
Sponsors and collaborators
Lead sponsor
Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies
Industry
Registry information
Official study title
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety, Pharmacokinetics and Efficacy of Intravenous Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labour
Important dates
- Study start
- 2005
- Primary completion
- 2006
- Study completion
- 2006
- First posted
- Nov 29, 2005
- Registry last updated
- May 7, 2014
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Impact of Timing of Neuraxial Analgesia on Obstetric, Anesthesiologic and Neonatal Outcomes in Induced Labour
NCT06886555
Duration of Labour, Labor, Induced
Pavia, Italy
View Trial DetailsShould I Have an Elective Induction?
NCT05838313
Behavior, Health Behavior
Tampa, Florida, United States
View Trial DetailsLabor Induction With Oral Versus Vaginal Misoprostol
NCT04755218
Labor, Induced, Pregnancy
Dallas, Texas, United States
View Trial DetailsEffect of Acidic Vaginal pH on the Efficacy of Dinoprostone for Labor Induction
NCT05100264
Induced; Birth, Labor, Induced
Athens, Greece
View Trial Details